Abbott Laboratories (BCBA:ABT)

Market Cap	302.12T
Revenue (ttm)	60.09T
Net Income (ttm)	19.09T
Shares Out	n/a
EPS (ttm)	10,910.24
PE Ratio	15.83
Forward PE	21.75
Dividend	583.94 (1.25%)
Ex-Dividend Date	Jan 15, 2026

Volume	209
Average Volume	465
Open	45,760
Previous Close	46,320
Day's Range	45,620 - 47,620
52-Week Range	32,625 - 53,525
Beta	n/a
RSI	41.47
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD